 |
|
Trends in Medical Use and Abuse of Opioid Analgesics
David E. Joranson, MSSW;
Karen M. Ryan, MA;
Aaron M. Gilson, PhD;
June L. Dahl, PhD
JAMA. 2000;283:1710-1714.
Context Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs.
Objective To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone.
Design and Setting Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data).
Patients Nationally representative sample of hospital emergency department admissions resulting from drug abuse.
Main Outcome Measures Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population.
Results From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865).
Conclusions The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.
Author Affiliations: Department of Pharmacology (Dr Dahl) and the Pain and Policy Studies Group, Comprehensive Cancer Center (Mr Joranson, Ms Ryan, and Dr Gilson), University of Wisconsin Medical School, Madison.
RELATED LETTER
Reporting Drug Abuse in the Emergency Department
Judy Ball, Samuel Korper, Albert Woodward, David E. Joranson, Karen M. Ryan, Aaron M. Gilson, and June L. Dahl
JAMA. 2000;284(5):564.
EXTRACT
| FULL TEXT
RELATED ARTICLES
April 5, 2000
JAMA. 2000;283(13):1759-1760.
EXTRACT
| FULL TEXT
Managing Pain
JAMA. 2000;283(13):1778.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Effect of Amitriptyline, Gabapentin, and Carbamazepine on Morphine-Induced Hypercarbia in Rabbits
Kozer et al.
Anesth. Analg. 2008;107:1216-1222.
ABSTRACT
| FULL TEXT
Screening for Drug Abuse Among Medical and Nonmedical Users of Prescription Drugs in a Probability Sample of College Students
McCabe
Arch Pediatr Adolesc Med 2008;162:225-231.
ABSTRACT
| FULL TEXT
Rates of Adverse Events of Long-Acting Opioids in a State Medicaid Program
Hartung et al.
The Annals of Pharmacotherapy 2007;41:921-928.
ABSTRACT
| FULL TEXT
Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory-Depressant Effect of Buprenorphine and Fentanyl in Rats
Yassen et al.
J. Pharmacol. Exp. Ther. 2006;319:682-692.
ABSTRACT
| FULL TEXT
Prescription Opioid Abuse in the Emergency Department
Wilsey et al.
J Law Med Ethics 2005;33:770-782.
Pharmacotherapy for cancer pain
G Oxberry and Simpson
Contin Educ Anaesth Crit Care Pain 2005;5:203-206.
FULL TEXT
Clinical implications of cyclo-oxygenase-2 inhibitors for acute dental pain management: Benefits and risks
SPINK et al.
Journal of the American Dental Association 2005;136:1439-1448.
ABSTRACT
| FULL TEXT
A day in the life of European palliative care
Cleary
Palliat Med 2005;19:442-443.
Treatment of chronic pain in persons with dementia: An overview
Rubey
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:12-20.
ABSTRACT
Oral Transmucosal Abuse of Transdermal Fentanyl
Liappas et al.
J Psychopharmacol 2004;18:277-280.
ABSTRACT
Editorial III: Opioids for persistent non-cancer pain: recommendations for clinical practice
Simpson
Br J Anaesth 2004;92:326-328.
FULL TEXT
Investigation of systems to prevent diversion of opiate drugs in general practice in the UK
Baker et al.
Qual Saf Health Care 2004;13:21-25.
ABSTRACT
| FULL TEXT
Reporting Drug Abuse in the Emergency Department
Ball et al.
JAMA 2000;284:564-564.
FULL TEXT
Pain Management and Opioid Use
JWatch Psychiatry 2000;2000:13-13.
FULL TEXT
|
